BACKGROUND: Many disease-specific, quality-of-life (QOL) instruments exist for chronic rhinosinusitis (CRS), resulting in confusion about the best application and use of each instrument. We hypothesized that the most prevalently utilized instruments do not strongly correlate in all domains, but rather act in complementary fashion for QOL assessment. METHODS: A systematic literature review (MEDLINE) was performed to identify the type and frequency of available CRS-specific QOL instruments. Univariate analyses of the 3 most common instruments (Rhinosinusitis Disability Index [RSDI], Chronic Sinusitis Survey [CSS] and 22-item Sinonasal Outcomes Test [SNOT-22]) were performed using a multi-institutional prospective cohort of sinusitis patients. RESULTS: Systematic literature review found that the SNOT-20 (and its derivatives), RSDI, and CSS are the most commonly utilized CRS-specific QOL instruments. The majority of RSDI domains were weakly or not correlated with the CSS domains (r = 0.097-0.501; p < 0.001). In contrast, the RSDI was highly correlated with the SNOT-22 (r ≥ 0.666; p < 0.001). Patients with asthma and/or allergies reported significantly worse CSS scores (p < 0.001). Comorbidities had no significant impact on RSDI or SNOT-22 responses. CONCLUSION: Different disease-specific CRS QOL instruments measure different aspects of the patient's experience. The RSDI and SNOT-22 are more sensitive to measuring the emotional impact of CRS, whereas the CSS examines medication use and symptoms. These instruments play complementary roles in the evaluation of CRS treatment outcomes.
BACKGROUND: Many disease-specific, quality-of-life (QOL) instruments exist for chronic rhinosinusitis (CRS), resulting in confusion about the best application and use of each instrument. We hypothesized that the most prevalently utilized instruments do not strongly correlate in all domains, but rather act in complementary fashion for QOL assessment. METHODS: A systematic literature review (MEDLINE) was performed to identify the type and frequency of available CRS-specific QOL instruments. Univariate analyses of the 3 most common instruments (Rhinosinusitis Disability Index [RSDI], Chronic Sinusitis Survey [CSS] and 22-item Sinonasal Outcomes Test [SNOT-22]) were performed using a multi-institutional prospective cohort of sinusitispatients. RESULTS: Systematic literature review found that the SNOT-20 (and its derivatives), RSDI, and CSS are the most commonly utilized CRS-specific QOL instruments. The majority of RSDI domains were weakly or not correlated with the CSS domains (r = 0.097-0.501; p < 0.001). In contrast, the RSDI was highly correlated with the SNOT-22 (r ≥ 0.666; p < 0.001). Patients with asthma and/or allergies reported significantly worse CSS scores (p < 0.001). Comorbidities had no significant impact on RSDI or SNOT-22 responses. CONCLUSION: Different disease-specific CRS QOL instruments measure different aspects of the patient's experience. The RSDI and SNOT-22 are more sensitive to measuring the emotional impact of CRS, whereas the CSS examines medication use and symptoms. These instruments play complementary roles in the evaluation of CRS treatment outcomes.
Authors: Michael S Benninger; Berrylin J Ferguson; James A Hadley; Daniel L Hamilos; Michael Jacobs; David W Kennedy; Donald C Lanza; Bradley F Marple; J David Osguthorpe; James A Stankiewicz; Jack Anon; James Denneny; Ivor Emanuel; Howard Levine Journal: Otolaryngol Head Neck Surg Date: 2003-09 Impact factor: 3.497
Authors: Adam S DeConde; Jess C Mace; Jeremiah A Alt; Luke Rudmik; Zachary M Soler; Timothy L Smith Journal: Int Forum Allergy Rhinol Date: 2014-12-15 Impact factor: 3.858
Authors: John F Pallanch; Lifeng Yu; David Delone; Rich Robb; David R Holmes; Jon Camp; Phil Edwards; Cynthia H McCollough; Jens Ponikau; Amy C Dearking; John Lane; Andrew Primak; Aaron Shinkle; John Hagan; Evangelo Frigas; Joseph J Ocel; Nicole Tombers; Rizwan Siwani; Nicholas M Orme; Kurtis B Reed; Nivedita Jerath; Robinder Dhillon; Hirohito Kita Journal: Int Forum Allergy Rhinol Date: 2013-09-17 Impact factor: 3.858
Authors: George S Tarasidis; Adam S DeConde; Jess C Mace; Shaelene Ashby; Timothy L Smith; Richard R Orlandi; Jeremiah A Alt Journal: Int Forum Allergy Rhinol Date: 2015-06-22 Impact factor: 3.858
Authors: Quinn Orb; Jess C Mace; Adam S DeConde; Toby O Steele; Steve T Cox; Timothy L Smith; Jeremiah A Alt Journal: Int Forum Allergy Rhinol Date: 2015-11-04 Impact factor: 3.858
Authors: Amarbir S Gill; Jess C Mace; Ryan Rimmer; Vijay R Ramakrishnan; Daniel M Beswick; Zachary M Soler; James Manor; Richard R Orlandi; Timothy L Smith; Jeremiah A Alt Journal: Int Forum Allergy Rhinol Date: 2021-07-14 Impact factor: 3.858
Authors: Michael Hoggard; Sharon Waldvogel-Thurlow; Melissa Zoing; Kevin Chang; Fiona J Radcliff; Brett Wagner Mackenzie; Kristi Biswas; Richard G Douglas; Michael W Taylor Journal: Front Immunol Date: 2018-09-19 Impact factor: 7.561